Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Non Operating Income (2016 - 2025)

Altimmune (ALT) has disclosed Other Non Operating Income for 16 consecutive years, with -$86000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income fell 577.78% to -$86000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$45000.0, a 10.0% increase, with the full-year FY2024 number at $48000.0, down 71.08% from a year prior.
  • Other Non Operating Income was -$86000.0 for Q3 2025 at Altimmune, up from -$92000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $118000.0 in Q4 2024 to a low of -$286000.0 in Q3 2021.
  • A 5-year average of -$18684.2 and a median of $15000.0 in 2025 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 542.33% in 2021; the steepest drop was 1078.85% in 2021.
  • Altimmune's Other Non Operating Income stood at -$81000.0 in 2021, then crashed by 167.9% to -$217000.0 in 2022, then soared by 109.22% to $20000.0 in 2023, then soared by 490.0% to $118000.0 in 2024, then crashed by 172.88% to -$86000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Other Non Operating Income are -$86000.0 (Q3 2025), -$92000.0 (Q2 2025), and $15000.0 (Q1 2025).